Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients

BACKGROUND: Reports of severe COVID-19 being associated with thrombosis, antiphospholipid antibodies (APLA), and antiphospholipid syndrome have yielded disparate conclusions. Studies comparing patients with COVID-19 with contemporaneous controls of similar severity are lacking. METHODS: 22 COVID-19(...

Descripción completa

Detalles Bibliográficos
Autores principales: Trahtemberg, Uriel, Rottapel, Robert, Dos Santos, Claudia C, Slutsky, Arthur S, Baker, Andrew, Fritzler, Marvin J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076626/
https://www.ncbi.nlm.nih.gov/pubmed/33903092
http://dx.doi.org/10.1136/annrheumdis-2021-220206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076626/
https://www.ncbi.nlm.nih.gov/pubmed/33903092
http://dx.doi.org/10.1136/annrheumdis-2021-220206

Ejemplares similares